Another two studies reported that IRS-954, an inhibitory DNA sequence against TLR7 and 9, and chloroquine, which inhibits TLR7 and 9 activation, significantly impeded tumor development and growth in vivo and in vitro in liver cancer (184) and cholangiocarcinoma models (185). This evidence concerns the gene TLR7 and cholangiocarcinoma.